Related Experiment Video
Updated: Dec 18, 2025
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
Laparoendoscopic single-site inguinal lymphadenectomy in gynecology: preliminary experience at a single institution
Jingyun Xu1, Kristina Duan2, Xiaoming Guan3
1Department of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, No.87, Hu South Road, Nanjing, 210009, Jiangsu, People's Republic of China.
Purpose:
Laparoendoscopic single-site surgery (LESS), a promising innovation in minimally invasive surgery, has been used in treating gynecologic oncology diseases. There have been no reports in the literature regarding LESS for inguinal lymphadenectomy (LESS-IL) in gynecologic conditions. We aimed to evaluate the feasibility, safety, and outcomes of LESS-IL.
Methods:
Six patients with vulvar or vaginal cancer underwent LESS-IL from July 2018 to March 2019. Data regarding the intraoperative and postoperative outcomes were analyzed.
Results:
All patients successfully underwent a bilateral LESS-IL without conversion. LESS pelvic lymphadenectomy via an umbilical incision was also performed in a patient with vaginal cancer. The median operation time for the single-port laparoendoscopic inguinal lymphadenectomies was 105 min (range 70-134), with a median estimated blood loss of 108 ml (range 40-170). Median time of hospitalization was 7.5 days (range 5-10). A median of 11 (6-15) lymph nodes were dissected in a unilateral groin. The suction drains were removed after a median duration of 5 days (range 3-7). There were no skin-related or lymph-related postoperative complications. At a median follow-up period of 9 months, all the patients were alive and no recurrence was found.
Conclusion:
LESS-IL is a feasible and safe technique for the surgical management of gynecologic cancers.
